MedTrace Logo

Interaction Between Anaesthetics and Methylene Blue

NCT00513032 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2007-08-08

No results posted yet for this study

Summary

We hypothesized that pre-treatment with methylene blue could potentiate the effects of general anaesthetic agents in patients undergoing parathyroidectomy

Conditions

  • Hyperparathyroidism

Interventions

DRUG

methylene blue

5mg.kg-1 methylene blue in 250 ml 5% glucose-saline, administered intravenously approximately 60 min before anaesthesia induction

Sponsors & Collaborators

  • University Hospital, Geneva

    lead OTHER

Principal Investigators

  • Marc Licker, MD · University Hospital, Geneva

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Completion
2007-04-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00513032 on ClinicalTrials.gov